Clinical Trial Update: A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating safety and efficacy of APO-2 at three doses in diabetic foot ulcers has completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• APO-2

Snippet

Sponsor: Aposcience AG | Conditions: Diabetic Foot Ulcer (DFU) | Phase 1, Phase 2 | Status: COMPLETED